Whether the seizure test profile of rapamycin in the kainic

Whether the seizure test profile of rapamycin in the kainic acid test is shared with inhibitors of voltagedependent sodium channel activity is less clear. Although kainic acid test results after short pretreatment with either phenytoin or lamotrigine are mixed, topiramate protects against kainic acid-induced clonic and tonic seizures, while rapamycin only mildly suppressed the mean seizure score and only during the final 30 min of the test. Despite trends for the other scoring criteria, they were not significant despite the number of animals we tested. Topiramate also has inhibitory effects on AMPA/kainate-type ionotropic glutamate receptors and calcium channels and enhances GABAA receptor function. The action of lamotrigine on N- and P-type calcium channels, unlike phenytoin and topiramate, could potentially explain differences in seizures profiles from rapamycin, although the mechanism of this effect remains unclear. The use of seizure-na?��ve, non-epileptic mice in this study allowed us to examine the short-term effects of rapamycin on nonpathological tissue. This is in contrast to long-term effects in disease models that may be dependent on a specific pathological context. The use of seizure-na?��ve, nonepileptic mice is a strategy that has successfully identified a wide variety of anticonvulsants used in the clinic. Although potentially useful in further exploring the antiseizure mechanisms of rapamycin, the use of normal mice prevents us from drawing conclusions about the effects of rapamycin on mice with epilepsy. Mirin Similar to rapamycin, the high-fat, low-carbohydrate ketogenic diet suppresses mTOR activity. The ketogenic diet has been suggested to decrease mTOR activity via increased AMPK activity. If rapamycin and the ketogenic diet share similar metabolic effects and anticonvulsant mechanisms as suggested, then rapamycin treatment could be expected to protect against 6 Hzinduced acute seizures, similar to the ketogenic diet. We found no such protection in the rapamycin dosing regimens studied here. To put these new Aucubin distributor findings in perspective with our ketogenic diet results, there was,1 mA difference in the mean CC50 between rapamycin- and vehicle-treated mice, in contrast to the 2 mA difference in CC50 between the ketogenic diet and normal diet. Thus,